Key statistics
As of last trade Transmedics Group Inc (8T8:DUS) traded at 109.05, -15.66% below its 52-week high of 129.30, set on Dec 02, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 108.80 |
|---|---|
| High | 109.05 |
| Low | 108.80 |
| Bid | 109.10 |
| Offer | 110.00 |
| Previous close | 107.85 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 34.17m |
| Free float | 33.17m |
| P/E (TTM) | 54.54 |
| Market cap | 4.44bn USD |
| EPS (TTM) | 2.38 USD |
Data delayed at least 15 minutes, as of Feb 16 2026 11:32 GMT.
More ▼
Press releases
- TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
- TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
- TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts
- TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference
More ▼
